Accent Microcell

Accent Microcell P/FCF

The P/FCF (Price-to-Free-Cash-Flow Ratio) of Accent Microcell (ACCENTMIC.NS) as of Oct 22, 2026 is 69.10. In the previous year, P/FCF (Price-to-Free-Cash-Flow Ratio) was 92.60 — a change of -25.38% (lower).

P/FCF

69.10

YoY

-25.38%

Last updated:

P/FCF (Price-to-Free-Cash-Flow Ratio) of Accent Microcell is 2025 69.10 . P/FCF (Price-to-Free-Cash-Flow Ratio) of Accent Microcell was 2024 92.60 . It decreases by -25.38% lower compared to the previous year.

The Accent Microcell P/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/FCF
Date
P/FCF
Jan 1, 2023
78.16 INR
Jan 1, 2024
92.60 INR
Jan 1, 2025
69.10 INR
The Accent Microcell P/FCF history
YEARP/FCFYoY
69.10-25.38%
92.60+18.48%
78.16—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Accent Microcell Stock analysis

What does Accent Microcell do? Accent Microcell Ltd develops, processes, and markets a wide range of pharmaceutical products including bulk drugs, formulations in all forms, feed and dietary supplements, and healthcare products across allopathic, ayurvedic, umami, homeopathic, and other branches. The company manufactures and sells antibiotics, herbal, bacteriological, and biological products, as well as insecticides, pesticides, fungicides, and disinfectants. With over 200 products in its portfolio, Accent Microcell targets therapeutic segments in human and veterinary healthcare, offering both raw materials and finished preparations for diverse medical applications. The company's product range includes microcrystalline cellulose powder and alpha cellulose powder, which are used as pharmaceutical excipients. Accent Microcell Limited deals in all kinds of drugs and medicines, covering various therapeutic areas such as antibiotics, herbal remedies, and veterinary applications. Its business model focuses on manufacturing, importing, and exporting these products to meet demand in multiple healthcare sectors. Accent Microcell Ltd's revenue streams come from selling bulk drugs, pharmaceutical formulations, and healthcare products to distributors, pharmacies, and veterinary suppliers. The company's diverse portfolio of over 200 products ensures steady demand across different therapeutic segments, supporting consistent sales in both human and veterinary healthcare markets. Accent Microcell is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Accent Microcell stock

P/FCF (Price-to-Free-Cash-Flow Ratio) of Accent Microcell is 69.10 in 2025.

P/FCF (Price-to-Free-Cash-Flow Ratio) of Accent Microcell changed from 92.60 to 69.10, representing a -25.38% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/FCF (Price-to-Free-Cash-Flow Ratio) Accent Microcell since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Free-Cash-Flow ratio measures how much investors pay for each unit of free cash flow. A lower ratio may indicate better value.

P/FCF = Market Capitalization / Free Cash Flow

To evaluate P/FCF (Price-to-Free-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/FCF (Price-to-Free-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/FCF (Price-to-Free-Cash-Flow Ratio)'s Accent Microcell with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Accent Microcell

All Key Metrics — Accent Microcell